Beyond Disease Management: Strategies for Improving Patient Care and Cutting Costs

Table of Contents

• Executive Summary
  • Strategic Considerations
  • Stakeholder Implications
• Introduction
• Evolution of Disease Management and Related Strategies
• Growing Demand for Disease Management and Related Strategies
• Challenges of Patient Enrollment
• Employers' Views on Disease Management
• Medicare Initiatives
• Medicaid and State Initiatives
  • Support from CMS
  • State Initiatives
• Outlook and Implications for the Pharmaceutical Industry

Sidebars

• What Is Disease Management?
• Florida Gives Manufacturer-Sponsored Disease Management Programs a Second Chance

Tables

• 1. U.S. Employers' Actual and Potential Use of Select Care Management Measures
• 2. Pharmaceutical Manufacturer-Sponsored Disease Management Programs Certified by the National Committee for Quality Assurance, November 2007

Figures

• 1. Percentage of U.S. Employers of Various Sizes That Offer Health Benefi ts and Disease Management Programs, 2006
• 2. Coverage of Key Indications in U.S. Employers' Disease Management Programs, 2006
• 3. Coverage of Select Indications in Disease Management Programs of Health Maintenance Organizations That Offer Disease Management, 2006
• 4. U.S. Employers' Perceptions of the Effectiveness of Disease Management as a Cost-Containment Measure, 2007